Thermo Fisher Scientific

1532 articles with Thermo Fisher Scientific

• The Phadia 2500+ Instrument Family Now Available in the U.S. for Autoimmune Testing

  5/26/2022

  The new Phadia 2500+ series of instruments is now available for autoimmune testing in the U.S. The family of high-capacity, intuitive lab instruments supplied by Thermo Fisher Scientific, the world leader in serving science, offers reliable and unparalleled high throughput for both allergy diagnostics and autoimmune testing.

• Thermo Fisher Scientific’s Clinical Research Business Receives ATD Award for Employee Talent Development

  5/24/2022

  The PPD clinical research business of Thermo Fisher Scientific has been recognized as one of the best in the world for its successful enterprise learning and development programs by the Association for Talent Development (ATD), a global organization that empowers professionals to develop talent in the workplace.

• Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine

  5/23/2022

  Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a as a step toward expanding the benefits of precision medicine across Arab populations globally.

• Thermo Fisher Scientific and LabShares Partner to Support Emerging Boston Biotechs

  5/19/2022

  To support the Greater Boston biotech ecosystem, Thermo Fisher Scientific is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumables to help early-stage life sciences companies accelerate their

• Thermo Fisher Scientific Declares Quarterly Dividend - May 19, 2022

  5/19/2022

  Thermo Fisher Scientific Inc., the world leader in serving science, announced that on May 18, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on July 15, 2022, to shareholders of record as of June 15, 2022.

• Thermo Fisher Scientific’s Clinical Research Business Honored in CRO Leadership Awards

  5/16/2022

  The PPD clinical research business of Thermo Fisher Scientific has been recognized for excellence in the 2022 CRO Leadership Awards.

• Thermo Fisher Scientific’s Clinical Research Business Named a Leader in Decentralized Clinical Trial Solutions by ISG

  5/12/2022

  The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been distinguished for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm.

• Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation

  5/11/2022

  Ionpath, Inc., a leader in high-definition spatial proteomics, announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company.

• Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance

  5/10/2022

  Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics.

• Thermo Fisher Scientific to Present at BofA Securities 2022 Healthcare Conference

  5/6/2022

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 12:20 p.m. (EDT).

• New Cation Trap Column Workflow Improves Uptime for Anionic Contaminants Testing of Industrial Waters

  5/4/2022

  Thermo Fisher Scientific Inc., the world leader in serving science, now offers nuclear power plants a new continuously regenerated cation trap column application workflow for robust and efficient trace anion contaminant testing of industrial waters.

• Thermo Fisher Scientific Reports First Quarter 2022 Results

  4/28/2022

  Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the first quarter ended April 2, 2022.

• Thermo Fisher Scientific’s Clinical Research Business Named “Best CRO” at Vaccine Industry Excellence Awards for Second Consecutive Year

  4/21/2022

  The PPD clinical research business of Thermo Fisher Scientific was named “Best Contract Research Organization” at the 15th annual Vaccine Industry Excellence (ViE) Awards during the 2022 World Vaccine Congress, recognizing its success in helping customers develop safe and effective vaccines to improve health and save lives.

• Portal Innovations Announces Partnership with Thermo Fisher Scientific

  4/21/2022

  Portal Innovations today announced that it is partnering with Life Technologies Corporation, part of Thermo Fisher Scientific Inc. (NYSE: TMO) the world leader in serving science and a leading life sciences research provider of innovative technologies.

• Thermo Fisher Scientific Opens Bioprocessing Manufacturing Site in Ogden, Utah

  4/20/2022

  Thermo Fisher Scientific celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah.

• Moderna and Thermo Fisher Scientific Honored for COVID-19 Vaccine Efforts

  4/14/2022

  The PPD clinical research business of Thermo Fisher Scientific and Moderna, whose pioneering mRNA vaccine for COVID has been administered to hundreds of millions globally.

• Thermo Fisher Scientific to Host Investor Day

  4/11/2022

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2022 Investor Day on Wednesday, May 18, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City.

• 

  In Pew Survey, Black Americans Express Concern About Potential for Research Misconduct

  4/8/2022

  55% of respondents describe misconduct by medical research scientists as being a moderate or a very big problem.

• Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 28, 2022

  4/5/2022

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2022 before the market opens on Thursday, April 28, 2022, and will hold a conference call on the same day at 8:30 a.m. EST.

• Thermo Fisher Scientific Launches User-Friendly Raman Spectroscopic Analyzer

  4/5/2022

  Thermo Fisher Scientific Launches User-Friendly Raman Spectroscopic Analyzer.